Institute for Advancing Medical Innovation Trailblazer Awards
Forecasted
Institute for Advancing Medical Innovation Trailblazer Awards support investigators developing drugs, devices, and diagnostics to accelerate translational research and advance product development.
Browse similar grants
Funder: Frontiers Clinical & Translational Science Institute
Due Dates (Anticipated): March 2027 (Application deadline)
Funding Amounts: Up to $25,000; up to one award for a one-year funding cycle
Summary: Supports early-stage development of novel drugs, devices, and diagnostics to generate publications, external funding, and product development opportunities.
Key Information: PIs must be Frontiers members employed at partner institutions, and projects must address translational science.
Description
The Institute for Advancing Medical Innovation (IAMI) Trailblazer Award is a Frontiers Clinical & Translational Science Institute pilot program supporting innovative clinical and translational science across scientific disciplines. It helps investigators develop novel drugs, devices, and diagnostics, generating results for impactful publications, successful external funding applications, and products entering IAMI’s development pipeline.
Supported work includes experimental therapeutics, drug and medical device development, biomarker discovery and validation, and entrepreneurship activities defining product development opportunities. Projects must go beyond advancing a specific disease or target: they must address a scientific or operational principle underlying translation and develop generalizable innovations that accelerate translational research. Research addressing the needs of the rare disease community receives special consideration, but is not required.
